Genomes
Seedtable Score
44
Startups
1
Funding Rounds
1
Investors
$20m
Money raised
Overview
Genomes, based in London, addresses a critical need in biotech and health tech with its user-owned genomics database platform. Unlike many solutions controlled by third-party companies or research institutions, Genomes allows individuals to own and manage their genomic information, addressing concerns over privacy and data misuse. By focusing on user empowerment, Genomes can attract consumers wary of data privacy issues. Backed by GEM Digital, the company is positioned to challenge traditional genomic data storage models and create a more transparent, user-centric approach to personal genomics.
- Website: https://genomes.io
- Business model: b2c
- Company size: 1 - 11 employees
- Headquarters: London, UK
- Founded: 2018
- Social accounts: Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (1)
Funding
Funding series
Funding Series Analysis
The company Genomes has raised a total of $20m in funding over 1 rounds.
Key Insights:
- Series A: $20m
Genomes Series A (2023, $20M)
$20m